Hexaware Technologies has announced significant changes to its Board composition and senior management roles, effective February 23, 2026. Mr. Alok Chandra Misra has been appointed as a Non-Executive Independent Additional Director for a three-year term. Conversely, Mr. Vivek Sharma has resigned as an Independent Director due to professional commitments. Additionally, Mr. Shantanu Baruah has taken on an expanded role as the North America – Hunting Head.
Key Changes in Board Composition
Hexaware Technologies Limited has informed the exchanges regarding crucial updates to its Board of Directors and committees, effective February 23, 2026.
Appointment of Mr. Alok Chandra Misra
The Board has approved the appointment of Mr. Alok Chandra Misra (DIN: 01542028) as an Additional Director in the capacity of Non-Executive Independent Director. This appointment is set for a term of three years, commencing from February 23, 2026, to February 22, 2029, pending shareholder approval. Mr. Misra brings extensive financial expertise, having previously served as Operating Partner at General Atlantic and Group CFO for WNS Group and MphasiS BFL Group.
In line with this appointment, Mr. Misra has been added as a member to several key committees:
- Audit Committee
- Nomination & Remuneration Committee
- Risk Management Committee
- Environmental, Social & Governance Committee
- Cybersecurity Committee (Sub-committee of the Audit Committee)
Resignation of Mr. Vivek Sharma
Mr. Vivek Sharma (DIN: 10741746) has resigned from his position as an Independent Director, effective from the close of business on February 23, 2026, citing other professional commitments. Consequently, he will also step down from his membership in the Stakeholders Relationship Committee and the Corporate Social Responsibility Committee.
Expansion of Senior Management Role
In a separate advisory move, the Board approved an additional role for a key executive.
Mr. Shantanu Baruah, currently the President & Global Head of the Healthcare & Insurance (H&I) Vertical, has been appointed to the additional role of North America – Hunting Head, effective from February 23, 2026. Mr. Baruah has over 25 years of experience in the healthcare and life sciences industry, previously leading the Healthcare business in North America as Executive Vice President at HCL Tech.
Committee Reconstitution Summary
The reconstitution of the Board committees following the changes is detailed, ensuring continuity in governance oversight. For instance, Mr. Milind Sarwate remains the Chairman of the Audit Committee and the Nomination & Remuneration Committee. Mr. Jospeh McLaren Quinlan will now chair the Risk Management Committee.
Source: BSE
